Investor Fights Illumina's Poison Pill Against Roche Bid

Law360, New York (March 7, 2012, 8:00 PM EST) -- Gene-sequencing firm Illumina Inc. was hit Tuesday with a proposed shareholder class action intended as an antidote to the company's recent poison pill efforts to resist a hostile takeover by Roche Holding AG.

The complaint in California federal court seeks to compel Illumina’s board to negotiate a sale, saying company leaders breached their fiduciary duty by rejecting a $5.7 billion bid from Roche and pursuing a defensive scheme to make a takeover unfeasible.

Under the poison pill plan, if Roche or another bidder gains control of...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Derfler v. Illumina, Inc. et al


Case Number

3:12-cv-00564

Court

California Southern

Nature of Suit

Securities/Commodities

Judge

Roger T. Benitez

Date Filed

March 5, 2012

Law Firms

Companies

Government Agencies

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.